Adina Croitoru

Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial

Roser Pinyol, Robert Montal, Laia Bassaganyas et al. · Gut · 2018 · 335 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Phase III Randomized Controlled Trial Comparing the Survival of Patients With Unresectable Hepatocellular Carcinoma Treated With Nolatrexed or Doxorubicin

Robert G. Gish, Camillo Porta, Lucian Lazar et al. · Journal of Clinical Oncology · 2007 · 280 citations

Medicine, Oncology, Pharmacotherapy +17

Cancer epidemiology in Central and South Eastern European countries

Eduard Vrdoljak, Marek Z. Wojtukiewicz, Tadeusz Pieńkowski et al. · Croatian Medical Journal · 2011 · 60 citations · Full text

Medicine, Health Sciences, Oncology +17

Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours

Éric Raymond, Matthew H. Kulke, Shukui Qin et al. · Neuroendocrinology · 2018 · 55 citations · Full text

Medicine, Oncology, Pharmacology +15

<i>KRAS</i>,<i>NRAS</i>and<i>BRAF</i>mutations in Greek and Romanian patients with colorectal cancer: a cohort study

Șerban Negru, Eirini Papadopoulou, Angela Apessos et al. · BMJ Open · 2014 · 44 citations · Full text

Medicine, Molecular Genetics, Oncology +17